| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2019916 | Prostaglandins & Other Lipid Mediators | 2009 | 6 Pages |
BackgroundInhaled PGE1 (IPGE1) is a potential pulmonary vasodilator in neonatal respiratory failure. However, its effect on the patency of the ductus arteriosus (DA) has not been described.ObjectiveTo investigate the effect of IPGE1 on the DA in healthy piglets.Design/methodsIPGE1 (1200 ng/kg/min) [Study] or nebulized saline [Control] was administered using a jet nebulizer. Transthoracic echocardiography (TTE) was performed prior to (T0) and after 24 h of aerosol therapy (T24). The DA was also evaluated histomorphologically at autopsy.ResultsFifteen piglets, 1–9 days old (study = 9; control = 6), were evaluated for DA patency. Study piglets received IPGE1 for 12–24 h. TTE was performed on 12 piglets at T0. Nine animals showed no ductal flow and 3 (1 study, 2 control) had a small DA. TTE at T24 in 5 animals showed no change in DA. At autopsy, the ductal diameter and histologic maturity stage were comparable in study and control animals.ConclusionsHigh dose IPGE1 given for 12–24 h does not exert significant effect on the DA of healthy term piglets as evaluated by echocardiography and histomorphology. We conclude that ductal patency in neonates is influenced not only by prostaglandins but also by factors like hypoxemia, prematurity, and heart disease.
